Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia

Haematologica. 2024 Feb 29. doi: 10.3324/haematol.2023.284271. Online ahead of print.

¹ Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA, Australia; Curtin Medical School, Curtin University, Perth, WA.
² Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA.
³ U1170 INSERM, Gustave Roussy, Villejuif.
⁴ Department of Hematology, St Jude Children's Hospital, Memphis, TN.
⁵ School of Chemistry, University of Sydney, NSW.
⁶ University Rouen Normandie, INSA Rouen Normandie, CNRS, COBRA UMR 6014, 76000.
⁷ Perha Pharmaceuticals, Perharidy Peninsula, Roscoff.
⁸ Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA, Australia; Curtin Medical School, Curtin University, Perth, WA, Australia; Curtin Health Innovation Research Institute, Curtin University, Perth, WA.
⁹ Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA, Australia; Curtin Medical School, Curtin University, Perth, WA, Australia; Department of Clinical Haematology, Oncology, Blood and Marrow Transplantation, Perth Children's Hospital, Perth, WA, Australia; University of Western Australia, Perth, WA.
¹⁰ Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA, Australia; Curtin Medical School, Curtin University, Perth, WA, Australia; University of Western Australia, Perth, WA. sebastien.malinge@telethonkids.org.au.

Abstract

Not available.